These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27053539)

  • 21. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothyroid heart: myxoedema as a cause of reversible dilated cardiomyopathy.
    Madan N; Tiwari N; Stampfer M; Schubart U
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26468223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiomyopathy as a severe, reversible side effect of doxorubicin (adriamycin)].
    Gerretsen M; Westerhof PW; Pinedo HM
    Ned Tijdschr Geneeskd; 1978 Jul; 122(30):1096-8. PubMed ID: 683357
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of tests for monitoring doxorubicin-induced cardiomyopathy.
    Ganz WI; Sridhar KS; Ganz SS; Gonzalez R; Chakko S; Serafini A
    Oncology; 1996; 53(6):461-70. PubMed ID: 8960141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of cardioxane (ICRF-187) in the prevention of cardiotoxicity of anthracyclines in the combined drug therapy of extensive ovarian cancer].
    Protasov DA; Zel'dovich DR; Kuz'mina LP; Manikhas GM
    Vopr Onkol; 1998; 44(6):718-21. PubMed ID: 10087973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthracycline antibiotics and the heart.
    Vaisrub S
    JAMA; 1977 Jul; 238(1):60. PubMed ID: 577267
    [No Abstract]   [Full Text] [Related]  

  • 27. Doxorubicin-induced cardiomyopathy.
    Muggia FM; Speyer JL
    N Engl J Med; 1999 Feb; 340(8):654-5. PubMed ID: 10049088
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathogenesis and prevention of doxorubicin cardiomyopathy.
    Ferrans VJ; Clark JR; Zhang J; Yu ZX; Herman EH
    Tsitologiia; 1997; 39(10):928-37. PubMed ID: 9505340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.
    Rudzinski T; Ciesielczyk M; Religa W; Bednarkiewicz Z; Krzeminska-Pakula M
    Europace; 2007 May; 9(5):278-80. PubMed ID: 17383986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
    Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
    N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
    Soker M; Kervancioglu M
    Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothyroid cardiomyopathy: a reversible form of systolic heart failure.
    Kirtane AJ; Manning WJ
    Am J Med; 2011 Dec; 124(12):e7. PubMed ID: 21906712
    [No Abstract]   [Full Text] [Related]  

  • 33. Doxorubicin-induced second degree and complete atrioventricular block.
    Kilickap S; Akgul E; Aksoy S; Aytemir K; Barista I
    Europace; 2005 May; 7(3):227-30. PubMed ID: 15878560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancing factors in the cardiotoxicity of anthracyclines].
    Sanz Manrique N; Valcarce Pérez J; Broto Escapa P; Escribano Subías J; Casaldáliga Ferrer J; Moraga Llop FA; Sánchez de Toledo Codina J
    An Esp Pediatr; 1990 Jan; 32(1):11-4. PubMed ID: 2327660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
    Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
    Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biventricular heart failure in patient treated with anthracycline in childhood: myocardial dysfunction is not always the cause].
    Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
    Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15185468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin in experimental and clinical heart failure.
    Christiansen S; Autschbach R
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare.
    Ward KM; Binns H; Chin C; Webber SA; Canter CE; Pahl E
    J Heart Lung Transplant; 2004 Sep; 23(9):1040-5. PubMed ID: 15454169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dilated cardiomyopathy post-chemotherapy].
    Sbrana F; Greco P; Rovai D
    Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic heart disease associated with vincristine and doxorubicin chemotherapy.
    Calvo-Romero JM; Fernández-Soria-Pantoja R; Arrebola-Garcia JD; Gil-Cubero M
    Ann Pharmacother; 2001 Nov; 35(11):1403-5. PubMed ID: 11724093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.